THE CHILDRENS HOSPITAL OF PHILADELPHIA FOUNDATION
Mission Statement
The Mitochondrial-Genetic Disease Clinic at Children's Hospital of Philadelphia is one of the top research centers in the nation for mitochondrial related diseases. Dr. Marni Falk and her colleagues are doing research on the specific genetic mutation and mitochondrial disease that Addison and Jacob have been diagnosed with. We believe that focusing our fundraising efforts specifically for Dr. Falk's lab at CHOP's Mitochondrial-Genetic Clinic is not only in the best interest of our children's future but also for those battling a Mitochondrial Disease. 100% of all contributions are tax deductible and will go directly to Dr. Falk's lab and her research on the FBXL4 gene mutation.
Financial Overview — FY 2023
Compared with Peers
FY 2023| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
76.0% | 87.3% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
15.3% | 12.7% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
8.8% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
721.2% | 478.2% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
146.7 mo | 6.0 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
41.4% | 46.1% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
55.9% | 96.8% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
30.6% | 6.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
12.0% | 6.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
44.2% | 1.3% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $377.6M | $210.7M | $2575.6M | 76.0% | 0 |
| 2022 | $289.2M | $188.2M | $2534.1M | 77.4% | 0 |
| 2021 | $328.7M | $167.8M | N/A | — | 0 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.